|
|||||
|
|
Race and mortality risk after radiation therapy in men treated with or without androgen‐suppression therapy for favorable‐risk prostate cancer |
|
| Authors: | Konstantin A. Kovtun MD Ming‐Hui Chen PhD Michelle H. Braccioforte MPH Brian J. Moran MD Anthony V. D'Amico MD PhD |
| Affiliation: | 1. Harvard Radiation Oncology Program, Brigham and Women's Hospital–Dana‐Farber Cancer Institute, Boston, Massachusetts;2. Department of Statistics, University of Connecticut, Storrs, Connecticut;3. Prostate Cancer Foundation of Chicago, Westmont, Illinois;4. Department of Radiation Oncology, Brigham and Women's Hospital–Dana‐Farber Cancer Institute, Boston, Massachusetts |
| Abstract: | |
| Keywords: | androgen‐deprivation therapy brachytherapy mortality prostate cancer race radiation therapy |